ID   OFUT2_HUMAN             Reviewed;         429 AA.
AC   Q9Y2G5; Q6PJV1; Q7Z4N0; Q8WWU6; Q9BQS4; Q9BQS5; Q9UFY3;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   15-FEB-2005, sequence version 3.
DT   28-JUN-2023, entry version 156.
DE   RecName: Full=GDP-fucose protein O-fucosyltransferase 2;
DE            EC=2.4.1.221 {ECO:0000269|PubMed:16464858, ECO:0000269|PubMed:22588082};
DE   AltName: Full=Peptide-O-fucosyltransferase 2;
DE            Short=O-FucT-2;
DE   Flags: Precursor;
GN   Name=POFUT2; Synonyms=C21orf80, FUT13, KIAA0958;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS A; B AND C), SUBCELLULAR LOCATION, AND
RP   TISSUE SPECIFICITY.
RX   PubMed=15233996; DOI=10.1016/j.ygeno.2004.04.002;
RA   Menzel O., Vellai T., Takacs-Vellai K., Reymond A., Mueller F.,
RA   Antonarakis S.E., Guipponi M.;
RT   "The Caenorhabditis elegans ortholog of C21orf80, a potential new protein
RT   O-fucosyltransferase, is required for normal development.";
RL   Genomics 84:320-330(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM C).
RX   PubMed=12966037; DOI=10.1093/glycob/cwg113;
RA   Martinez-Duncker I., Mollicone R., Candelier J.-J., Breton C., Oriol R.;
RT   "A new superfamily of protein-O-fucosyltransferases, alpha2-
RT   fucosyltransferases, and alpha6-fucosyltransferases: phylogeny and
RT   identification of conserved peptide motifs.";
RL   Glycobiology 13:1C-5C(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM A).
RC   TISSUE=Brain;
RX   PubMed=10231032; DOI=10.1093/dnares/6.1.63;
RA   Nagase T., Ishikawa K., Suyama M., Kikuno R., Hirosawa M., Miyajima N.,
RA   Tanaka A., Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XIII. The
RT   complete sequences of 100 new cDNA clones from brain which code for large
RT   proteins in vitro.";
RL   DNA Res. 6:63-70(1999).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM B).
RC   TISSUE=Testis;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=10830953; DOI=10.1038/35012518;
RA   Hattori M., Fujiyama A., Taylor T.D., Watanabe H., Yada T., Park H.-S.,
RA   Toyoda A., Ishii K., Totoki Y., Choi D.-K., Groner Y., Soeda E., Ohki M.,
RA   Takagi T., Sakaki Y., Taudien S., Blechschmidt K., Polley A., Menzel U.,
RA   Delabar J., Kumpf K., Lehmann R., Patterson D., Reichwald K., Rump A.,
RA   Schillhabel M., Schudy A., Zimmermann W., Rosenthal A., Kudoh J.,
RA   Shibuya K., Kawasaki K., Asakawa S., Shintani A., Sasaki T., Nagamine K.,
RA   Mitsuyama S., Antonarakis S.E., Minoshima S., Shimizu N., Nordsiek G.,
RA   Hornischer K., Brandt P., Scharfe M., Schoen O., Desario A., Reichelt J.,
RA   Kauer G., Bloecker H., Ramser J., Beck A., Klages S., Hennig S.,
RA   Riesselmann L., Dagand E., Wehrmeyer S., Borzym K., Gardiner K.,
RA   Nizetic D., Francis F., Lehrach H., Reinhardt R., Yaspo M.-L.;
RT   "The DNA sequence of human chromosome 21.";
RL   Nature 405:311-319(2000).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS B AND C).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   FUNCTION.
RX   PubMed=11067851; DOI=10.1074/jbc.m008073200;
RA   Hofsteenge J., Huwiler K.G., Macek B., Hess D., Lawler J., Mosher D.F.,
RA   Peter-Katalinic J.;
RT   "C-mannosylation and O-fucosylation of the thrombospondin type 1 module.";
RL   J. Biol. Chem. 276:6485-6498(2001).
RN   [8]
RP   FUNCTION, CATALYTIC ACTIVITY, AND PATHWAY.
RX   PubMed=16464858; DOI=10.1074/jbc.m511974200;
RA   Luo Y., Nita-Lazar A., Haltiwanger R.S.;
RT   "Two distinct pathways for O-fucosylation of epidermal growth factor-like
RT   or thrombospondin type 1 repeats.";
RL   J. Biol. Chem. 281:9385-9392(2006).
RN   [9]
RP   FUNCTION, AND MUTAGENESIS OF GLU-395 AND GLU-396.
RX   PubMed=17395589; DOI=10.1074/jbc.m700317200;
RA   Ricketts L.M., Dlugosz M., Luther K.B., Haltiwanger R.S., Majerus E.M.;
RT   "O-fucosylation is required for ADAMTS13 secretion.";
RL   J. Biol. Chem. 282:17014-17023(2007).
RN   [10]
RP   FUNCTION.
RX   PubMed=17395588; DOI=10.1074/jbc.m701065200;
RA   Wang L.W., Dlugosz M., Somerville R.P., Raed M., Haltiwanger R.S.,
RA   Apte S.S.;
RT   "O-fucosylation of thrombospondin type 1 repeats in ADAMTS-like-1/punctin-1
RT   regulates secretion: implications for the ADAMTS superfamily.";
RL   J. Biol. Chem. 282:17024-17031(2007).
RN   [11]
RP   CLEAVAGE OF SIGNAL PEPTIDE [LARGE SCALE ANALYSIS] AFTER ALA-21, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (3.0 ANGSTROMS) OF 22-429 IN COMPLEX WITH GDP-FUCOSE,
RP   FUNCTION, CATALYTIC ACTIVITY, ACTIVITY REGULATION, BIOPHYSICOCHEMICAL
RP   PROPERTIES, PATHWAY, MUTAGENESIS OF GLU-54; TRP-92; TRP-152; TRP-273;
RP   ARG-294; ASP-297 AND GLU-396, GLYCOSYLATION AT ASN-189 AND ASN-259, AND
RP   DISULFIDE BONDS.
RX   PubMed=22588082; DOI=10.1038/emboj.2012.143;
RA   Chen C.I., Keusch J.J., Klein D., Hess D., Hofsteenge J., Gut H.;
RT   "Structure of human POFUT2: insights into thrombospondin type 1 repeat fold
RT   and O-fucosylation.";
RL   EMBO J. 31:3183-3197(2012).
CC   -!- FUNCTION: Catalyzes the reaction that attaches fucose through an O-
CC       glycosidic linkage to a conserved serine or threonine residue in the
CC       consensus sequence C1-X-X-S/T-C2 of thrombospondin type I repeats
CC       (TSRs) where C1 and C2 are the first and second cysteines of the
CC       repeat, respectively (PubMed:22588082). O-fucosylates members of
CC       several protein families including the ADAMTS, the thrombospondin (TSP)
CC       and spondin families (Probable) (PubMed:17395588). Required for the
CC       proper secretion of ADAMTS family members such as ADAMTSL1 and ADAMTS13
CC       (PubMed:17395589, PubMed:17395588). The O-fucosylation of TSRs is also
CC       required for restricting epithelial to mesenchymal transition (EMT),
CC       maintaining the correct patterning of mesoderm and localization of the
CC       definite endoderm (By similarity). {ECO:0000250|UniProtKB:Q8VHI3,
CC       ECO:0000269|PubMed:17395588, ECO:0000269|PubMed:17395589,
CC       ECO:0000269|PubMed:22588082, ECO:0000305|PubMed:11067851,
CC       ECO:0000305|PubMed:16464858}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=GDP-beta-L-fucose + L-seryl-[protein] = 3-O-(alpha-L-fucosyl)-
CC         L-seryl-[protein] + GDP + H(+); Xref=Rhea:RHEA:63644, Rhea:RHEA-
CC         COMP:9863, Rhea:RHEA-COMP:17914, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:29999, ChEBI:CHEBI:57273, ChEBI:CHEBI:58189,
CC         ChEBI:CHEBI:189632; EC=2.4.1.221;
CC         Evidence={ECO:0000269|PubMed:16464858, ECO:0000269|PubMed:22588082};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:63645;
CC         Evidence={ECO:0000269|PubMed:16464858, ECO:0000269|PubMed:22588082};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=GDP-beta-L-fucose + L-threonyl-[protein] = 3-O-(alpha-L-
CC         fucosyl)-L-threonyl-[protein] + GDP + H(+); Xref=Rhea:RHEA:70491,
CC         Rhea:RHEA-COMP:11060, Rhea:RHEA-COMP:17915, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30013, ChEBI:CHEBI:57273, ChEBI:CHEBI:58189,
CC         ChEBI:CHEBI:189631; EC=2.4.1.221;
CC         Evidence={ECO:0000269|PubMed:16464858, ECO:0000269|PubMed:22588082};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:70492;
CC         Evidence={ECO:0000269|PubMed:16464858, ECO:0000269|PubMed:22588082};
CC   -!- ACTIVITY REGULATION: Inhibited by EDTA and by Zn(2+).
CC       {ECO:0000269|PubMed:22588082}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=9.8 uM for GDP-fucose {ECO:0000269|PubMed:22588082};
CC   -!- PATHWAY: Protein modification; protein glycosylation.
CC       {ECO:0000269|PubMed:16464858, ECO:0000269|PubMed:22588082}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum
CC       {ECO:0000269|PubMed:15233996}. Golgi apparatus
CC       {ECO:0000269|PubMed:15233996}. Note=Mainly located in the endoplasmic
CC       reticulum. {ECO:0000269|PubMed:15233996}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=C;
CC         IsoId=Q9Y2G5-3; Sequence=Displayed;
CC       Name=A;
CC         IsoId=Q9Y2G5-1; Sequence=VSP_003832;
CC       Name=B;
CC         IsoId=Q9Y2G5-2; Sequence=VSP_003833, VSP_003834;
CC   -!- TISSUE SPECIFICITY: Isoform A is expressed in fetal liver and
CC       peripheral blood lymphocytes. Isoform B is expressed in spleen, lung,
CC       testis, bone marrow, thymus, pancreas, prostate, fetal brain, fetal
CC       liver and fetal kidney. Isoform C is expressed in brain, heart, spleen,
CC       liver, lung, stomach, testis, placenta, skin, thymus, pancreas, mammary
CC       gland, prostate, fetal brain, fetal liver and fetal heart.
CC       {ECO:0000269|PubMed:15233996}.
CC   -!- SIMILARITY: Belongs to the glycosyltransferase 68 family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA76802.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC       Sequence=CAB90496.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Functional Glycomics Gateway - GTase;
CC       Note=Peptide-O-fucosyltransferase 2;
CC       URL="http://www.functionalglycomics.org/glycomics/molecule/jsp/glycoEnzyme/viewGlycoEnzyme.jsp?gbpId=gt_hum_610";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ302080; CAC24557.1; -; mRNA.
DR   EMBL; AJ302079; CAC24556.1; -; mRNA.
DR   EMBL; AY066015; AAL47681.2; -; mRNA.
DR   EMBL; AJ575591; CAE01472.1; -; mRNA.
DR   EMBL; AB023175; BAA76802.1; ALT_INIT; mRNA.
DR   EMBL; AL110285; CAB53715.2; -; mRNA.
DR   EMBL; AL163301; CAB90496.1; ALT_INIT; Genomic_DNA.
DR   EMBL; BC011044; AAH11044.1; -; mRNA.
DR   EMBL; BC064623; AAH64623.1; -; mRNA.
DR   CCDS; CCDS13719.1; -. [Q9Y2G5-3]
DR   CCDS; CCDS13721.1; -. [Q9Y2G5-1]
DR   RefSeq; NP_056042.1; NM_015227.4. [Q9Y2G5-1]
DR   RefSeq; NP_598368.2; NM_133635.4. [Q9Y2G5-3]
DR   PDB; 4AP5; X-ray; 3.00 A; A/B=22-429.
DR   PDB; 4AP6; X-ray; 3.40 A; A/B/C/D=37-429.
DR   PDBsum; 4AP5; -.
DR   PDBsum; 4AP6; -.
DR   AlphaFoldDB; Q9Y2G5; -.
DR   SMR; Q9Y2G5; -.
DR   BioGRID; 116876; 12.
DR   IntAct; Q9Y2G5; 4.
DR   STRING; 9606.ENSP00000339613; -.
DR   CAZy; GT68; Glycosyltransferase Family 68.
DR   GlyCosmos; Q9Y2G5; 3 sites, No reported glycans.
DR   GlyGen; Q9Y2G5; 4 sites, 1 O-linked glycan (1 site).
DR   iPTMnet; Q9Y2G5; -.
DR   PhosphoSitePlus; Q9Y2G5; -.
DR   BioMuta; POFUT2; -.
DR   DMDM; 59803123; -.
DR   EPD; Q9Y2G5; -.
DR   jPOST; Q9Y2G5; -.
DR   MassIVE; Q9Y2G5; -.
DR   MaxQB; Q9Y2G5; -.
DR   PaxDb; Q9Y2G5; -.
DR   PeptideAtlas; Q9Y2G5; -.
DR   ProteomicsDB; 85769; -. [Q9Y2G5-3]
DR   ProteomicsDB; 85770; -. [Q9Y2G5-1]
DR   ProteomicsDB; 85771; -. [Q9Y2G5-2]
DR   Antibodypedia; 10462; 332 antibodies from 29 providers.
DR   DNASU; 23275; -.
DR   Ensembl; ENST00000331343.11; ENSP00000329682.7; ENSG00000186866.17. [Q9Y2G5-1]
DR   Ensembl; ENST00000334538.13; ENSP00000335427.9; ENSG00000186866.17. [Q9Y2G5-2]
DR   Ensembl; ENST00000349485.10; ENSP00000339613.5; ENSG00000186866.17. [Q9Y2G5-3]
DR   GeneID; 23275; -.
DR   KEGG; hsa:23275; -.
DR   MANE-Select; ENST00000349485.10; ENSP00000339613.5; NM_133635.6; NP_598368.2.
DR   UCSC; uc002zhb.4; human. [Q9Y2G5-3]
DR   AGR; HGNC:14683; -.
DR   CTD; 23275; -.
DR   DisGeNET; 23275; -.
DR   GeneCards; POFUT2; -.
DR   HGNC; HGNC:14683; POFUT2.
DR   HPA; ENSG00000186866; Low tissue specificity.
DR   MIM; 610249; gene.
DR   neXtProt; NX_Q9Y2G5; -.
DR   OpenTargets; ENSG00000186866; -.
DR   PharmGKB; PA25867; -.
DR   VEuPathDB; HostDB:ENSG00000186866; -.
DR   eggNOG; ENOG502QPS6; Eukaryota.
DR   GeneTree; ENSGT00390000007989; -.
DR   HOGENOM; CLU_033856_0_0_1; -.
DR   InParanoid; Q9Y2G5; -.
DR   OMA; YILYDVN; -.
DR   OrthoDB; 197532at2759; -.
DR   PhylomeDB; Q9Y2G5; -.
DR   TreeFam; TF314337; -.
DR   BRENDA; 2.4.1.221; 2681.
DR   PathwayCommons; Q9Y2G5; -.
DR   Reactome; R-HSA-5173214; O-glycosylation of TSR domain-containing proteins.
DR   SignaLink; Q9Y2G5; -.
DR   UniPathway; UPA00378; -.
DR   BioGRID-ORCS; 23275; 15 hits in 1155 CRISPR screens.
DR   GenomeRNAi; 23275; -.
DR   Pharos; Q9Y2G5; Tbio.
DR   PRO; PR:Q9Y2G5; -.
DR   Proteomes; UP000005640; Chromosome 21.
DR   RNAct; Q9Y2G5; protein.
DR   Bgee; ENSG00000186866; Expressed in right uterine tube and 183 other tissues.
DR   ExpressionAtlas; Q9Y2G5; baseline and differential.
DR   Genevisible; Q9Y2G5; HS.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:UniProtKB.
DR   GO; GO:0046922; F:peptide-O-fucosyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0006004; P:fucose metabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0001707; P:mesoderm formation; IEA:Ensembl.
DR   GO; GO:1903334; P:positive regulation of protein folding; IMP:CACAO.
DR   GO; GO:0036066; P:protein O-linked fucosylation; IDA:UniProtKB.
DR   GO; GO:0010717; P:regulation of epithelial to mesenchymal transition; IEA:Ensembl.
DR   GO; GO:0010468; P:regulation of gene expression; IEA:Ensembl.
DR   GO; GO:0051046; P:regulation of secretion; IDA:UniProtKB.
DR   CDD; cd11298; O-FucT-2; 1.
DR   Gene3D; 3.40.50.11340; -; 1.
DR   Gene3D; 3.40.50.11350; -; 1.
DR   InterPro; IPR019378; GDP-Fuc_O-FucTrfase.
DR   InterPro; IPR045130; OFUT2-like.
DR   PANTHER; PTHR13398; GDP-FUCOSE PROTEIN O-FUCOSYLTRANSFERASE 2; 1.
DR   PANTHER; PTHR13398:SF0; GDP-FUCOSE PROTEIN O-FUCOSYLTRANSFERASE 2; 1.
DR   Pfam; PF10250; O-FucT; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Carbohydrate metabolism;
KW   Disulfide bond; Endoplasmic reticulum; Fucose metabolism; Glycoprotein;
KW   Glycosyltransferase; Golgi apparatus; Reference proteome; Signal;
KW   Transferase.
FT   SIGNAL          1..21
FT                   /evidence="ECO:0000255, ECO:0007744|PubMed:25944712"
FT   CHAIN           22..429
FT                   /note="GDP-fucose protein O-fucosyltransferase 2"
FT                   /id="PRO_0000012154"
FT   ACT_SITE        54
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000305|PubMed:22588082"
FT   BINDING         53..57
FT                   /ligand="GDP-beta-L-fucose"
FT                   /ligand_id="ChEBI:CHEBI:57273"
FT                   /evidence="ECO:0000269|PubMed:22588082,
FT                   ECO:0007744|PDB:4AP6"
FT   BINDING         292..294
FT                   /ligand="GDP-beta-L-fucose"
FT                   /ligand_id="ChEBI:CHEBI:57273"
FT                   /evidence="ECO:0000269|PubMed:22588082,
FT                   ECO:0007744|PDB:4AP6"
FT   BINDING         371
FT                   /ligand="GDP-beta-L-fucose"
FT                   /ligand_id="ChEBI:CHEBI:57273"
FT                   /evidence="ECO:0000269|PubMed:22588082,
FT                   ECO:0007744|PDB:4AP6"
FT   BINDING         388..389
FT                   /ligand="GDP-beta-L-fucose"
FT                   /ligand_id="ChEBI:CHEBI:57273"
FT                   /evidence="ECO:0000269|PubMed:22588082,
FT                   ECO:0007744|PDB:4AP6"
FT   SITE            396
FT                   /note="Essential for catalytic activity"
FT                   /evidence="ECO:0000269|PubMed:17395589,
FT                   ECO:0000269|PubMed:22588082"
FT   CARBOHYD        189
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:22588082"
FT   CARBOHYD        209
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        259
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:22588082"
FT   DISULFID        161..192
FT                   /evidence="ECO:0000269|PubMed:22588082,
FT                   ECO:0007744|PDB:4AP5, ECO:0007744|PDB:4AP6"
FT   DISULFID        412..419
FT                   /evidence="ECO:0000269|PubMed:22588082,
FT                   ECO:0007744|PDB:4AP5, ECO:0007744|PDB:4AP6"
FT   VAR_SEQ         379..380
FT                   /note="RF -> SS (in isoform B)"
FT                   /evidence="ECO:0000303|PubMed:15233996,
FT                   ECO:0000303|PubMed:15489334, ECO:0000303|PubMed:17974005"
FT                   /id="VSP_003833"
FT   VAR_SEQ         380..429
FT                   /note="FFIGTSVSTFSFRIHEEREILGLDPKTTYNRFCGDQEKACEQPTHWKITY
FT                   -> CLPTSLSAESGSGGFQRFFCPKYSVSEQMVACVHSGHFHTVCLLV (in
FT                   isoform A)"
FT                   /evidence="ECO:0000303|PubMed:10231032,
FT                   ECO:0000303|PubMed:15233996"
FT                   /id="VSP_003832"
FT   VAR_SEQ         381..429
FT                   /note="Missing (in isoform B)"
FT                   /evidence="ECO:0000303|PubMed:15233996,
FT                   ECO:0000303|PubMed:15489334, ECO:0000303|PubMed:17974005"
FT                   /id="VSP_003834"
FT   MUTAGEN         54
FT                   /note="E->A: Abolishes enzyme activity."
FT                   /evidence="ECO:0000269|PubMed:22588082"
FT   MUTAGEN         92
FT                   /note="W->A: Abolishes enzyme activity."
FT                   /evidence="ECO:0000269|PubMed:22588082"
FT   MUTAGEN         152
FT                   /note="W->A: Reduces enzyme activity."
FT                   /evidence="ECO:0000269|PubMed:22588082"
FT   MUTAGEN         273
FT                   /note="W->A: Reduces enzyme activity."
FT                   /evidence="ECO:0000269|PubMed:22588082"
FT   MUTAGEN         294
FT                   /note="R->A: Abolishes enzyme activity."
FT                   /evidence="ECO:0000269|PubMed:22588082"
FT   MUTAGEN         297
FT                   /note="D->A: Reduces enzyme activity."
FT                   /evidence="ECO:0000269|PubMed:22588082"
FT   MUTAGEN         395
FT                   /note="E->A: No enhanced secretion of ADASMTS13; when
FT                   associated with A-396."
FT                   /evidence="ECO:0000269|PubMed:17395589"
FT   MUTAGEN         396
FT                   /note="E->A: Reduces enzyme activity. No enhanced secretion
FT                   of ADASMTS13; when associated with A-396."
FT                   /evidence="ECO:0000269|PubMed:17395589,
FT                   ECO:0000269|PubMed:22588082"
FT   STRAND          44..48
FT                   /evidence="ECO:0007829|PDB:4AP5"
FT   HELIX           56..74
FT                   /evidence="ECO:0007829|PDB:4AP5"
FT   STRAND          79..83
FT                   /evidence="ECO:0007829|PDB:4AP5"
FT   HELIX           91..93
FT                   /evidence="ECO:0007829|PDB:4AP5"
FT   HELIX           104..106
FT                   /evidence="ECO:0007829|PDB:4AP5"
FT   HELIX           110..114
FT                   /evidence="ECO:0007829|PDB:4AP5"
FT   STRAND          119..121
FT                   /evidence="ECO:0007829|PDB:4AP5"
FT   HELIX           122..128
FT                   /evidence="ECO:0007829|PDB:4AP5"
FT   STRAND          129..141
FT                   /evidence="ECO:0007829|PDB:4AP5"
FT   STRAND          156..159
FT                   /evidence="ECO:0007829|PDB:4AP5"
FT   HELIX           179..181
FT                   /evidence="ECO:0007829|PDB:4AP5"
FT   STRAND          186..195
FT                   /evidence="ECO:0007829|PDB:4AP5"
FT   HELIX           199..202
FT                   /evidence="ECO:0007829|PDB:4AP5"
FT   HELIX           203..208
FT                   /evidence="ECO:0007829|PDB:4AP5"
FT   STRAND          213..219
FT                   /evidence="ECO:0007829|PDB:4AP5"
FT   HELIX           220..222
FT                   /evidence="ECO:0007829|PDB:4AP5"
FT   HELIX           231..238
FT                   /evidence="ECO:0007829|PDB:4AP5"
FT   HELIX           244..258
FT                   /evidence="ECO:0007829|PDB:4AP5"
FT   TURN            262..266
FT                   /evidence="ECO:0007829|PDB:4AP5"
FT   HELIX           273..275
FT                   /evidence="ECO:0007829|PDB:4AP5"
FT   STRAND          286..293
FT                   /evidence="ECO:0007829|PDB:4AP5"
FT   TURN            296..302
FT                   /evidence="ECO:0007829|PDB:4AP5"
FT   STRAND          304..306
FT                   /evidence="ECO:0007829|PDB:4AP5"
FT   HELIX           309..323
FT                   /evidence="ECO:0007829|PDB:4AP5"
FT   STRAND          328..332
FT                   /evidence="ECO:0007829|PDB:4AP5"
FT   HELIX           336..345
FT                   /evidence="ECO:0007829|PDB:4AP5"
FT   STRAND          349..351
FT                   /evidence="ECO:0007829|PDB:4AP6"
FT   HELIX           356..376
FT                   /evidence="ECO:0007829|PDB:4AP5"
FT   STRAND          378..383
FT                   /evidence="ECO:0007829|PDB:4AP5"
FT   HELIX           388..400
FT                   /evidence="ECO:0007829|PDB:4AP5"
FT   HELIX           404..406
FT                   /evidence="ECO:0007829|PDB:4AP5"
SQ   SEQUENCE   429 AA;  49976 MW;  36A4213D905AFFD1 CRC64;
     MATLSFVFLL LGAVSWPPAS ASGQEFWPGQ SAADILSGAA SRRRYLLYDV NPPEGFNLRR
     DVYIRIASLL KTLLKTEEWV LVLPPWGRLY HWQSPDIHQV RIPWSEFFDL PSLNKNIPVI
     EYEQFIAESG GPFIDQVYVL QSYAEGWKEG TWEEKVDERP CIDQLLYSQD KHEYYRGWFW
     GYEETRGLNV SCLSVQGSAS IVAPLLLRNT SARSVMLDRA ENLLHDHYGG KEYWDTRRSM
     VFARHLREVG DEFRSRHLNS TDDADRIPFQ EDWMKMKVKL GSALGGPYLG VHLRRKDFIW
     GHRQDVPSLE GAVRKIRSLM KTHRLDKVFV ATDAVRKEYE ELKKLLPEMV RFEPTWEELE
     LYKDGGVAII DQWICAHARF FIGTSVSTFS FRIHEEREIL GLDPKTTYNR FCGDQEKACE
     QPTHWKITY
//
